Aldevron is privileged to work with some of the most innovative and groundbreaking companies, academic institutions, and government laboratories in biotechnology today. Since the company’s founding 20 years ago, Michael Chambers and John Ballantyne have always focused on clients, with the goal to improve the lives of the customers and patients they serve. Researchers across the globe are making tremendous breakthroughs in gene and cell therapy and gene editing, resulting in advances in medicine, agriculture, energy and many other fields. We are honored to serve as the basis for many of these transformative products.
Starting out, Aldevron founders Michael Chambers and John Ballantyne had one thing in common besides being fascinated with biotechnology and its applications in health care. They are both graduates of North Dakota State University (NDSU) in Fargo.